FDA Clearance Tracker · P180032-S023
Cerene® Cryotherapy Device
Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 8, 2026
Approved
Time to decision
26 days
Received Jun 12, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P180032-S023
- Device name
- Cerene® Cryotherapy Device
- Applicant
- Channel Medsystems, Inc.
- Applicant location
- Emeryville, CA
- Received
- Jun 12, 2026
- Decided
- Jul 8, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P180032
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
The recommended decision for this file is Approve PMA GMP without inspection. This recommendation is based on transferring a low-risk labeling activity to a manufacturing site (and sponsor) previously approved under the PMA.
Source documents
Other decisions for Channel Medsystems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P180032 · Decided Mar 28, 2019 · 227 days after receipt
Device type: Device, thermal ablation, endometrial (MNB) · Obstetrics & Gynecology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.